To this end, we modulated PTTG1 protein levels in JKT-1 and SEM-1 seminoma cell lines, which show a more aggressive phenotype among the seminoma lines, and we evaluated the expression of E-CAD, since it is known that its decreased expression is one of the earliest steps in the EMT process. The gene discussed is PTTG1; the disease is seminoma.